20 likes | 40 Views
The total prevalent cases of Dilated Cardiomyopathy in the 7MM are expected to be 2,523,808 in 2020.<br><br>The Dilated Cardiomyopathy market is expected to grow with a CAGR of 13.1% in the 7MM during the study period (2017u20132030). <br><br>Increasing prevalence rate, increased healthcare spending, and emerging treatment options are some of the key factors expected to drive the Dilated Cardiomyopathy market in the upcoming years.<br><br>The key players in the Dilated Cardiomyopathy market include Pfizer, MyoKardia, Capricor Therapeutics, Vericel Corporation, Berlin Cures, Cumberland Pharmaceuticals and many others.<br><br>For more details visit: https://www.delveinsight.com/report-store/dilated-cardiomyopathy-dcm-market-insights<br><br>
E N D